NicOx ABPM Trial Shows Favorable Blood Pressure Profile For Naproxcinod
Sat, 09 Dec 2006 08:00 AM EST
... NicOx S.A. (Eurolist: NICOX) today announced top-line results from a pharmacodynamic clinical study utilizing Ambulatory Blood Pressure Monitoring (ABPM), which demonstrated a differentiated and favorable 24 hour blood pressure profile for naproxcinod, compared to naproxen, in hypertensive subjects after two weeks. [click link for full article] ...
Related Topics
- Low Blood Pressure
- Blood Pressure
- Hypertension
- Clinical Trials
- Lipid Profile
- Laboratory Tests
- Blood/Blood Transfusion
- Blood Transfusion
- Olmesartan
- Medications
- Blood Disorders
- Blood Donation
- Medication
- High Blood Pressure and Kidney Disease
- Blood in Urine
- Hydrocephalus - Normal Pressure
- Normal Pressure Hydrocephalus
- Raised Blood Pressure
- Blood Pressure Medications
- Blood Pressure, High

Not Signed In -


